Sparganosis, a zoonotic infection caused by the plerocercoid (sparganum) larval stage of Spirometra spp., is rarely reported in domestic cats. Sparganosis is typically seen as subcutaneous or visceral granulomatous lesions and has been associated with Spirometra mansonoides in North America. A proliferative form of sparganosis, with tissue invasion and widespread dissemination, has always been associated with Sparganum proliferum . However, emerging molecular evidence challenges this distinction. Here, we report a confirmed case of proliferative sparganosis in a domestic cat caused by Spirometra decipiens complex 2 (also referred to as Spirometra sp. 3). The cat had widespread lesions in multiple tissues, with gross and histologic lesions resembling those attributed to S. proliferum . Molecular identification of larval cestode DNA demonstrated a 99% match to S. decipiens , confirming its role in severe disseminated disease. Our case broadens the understanding of the pathogenic capacity of S. decipiens ( Spirometra sp. 3) in felids and emphasizes the critical role of molecular detection for accurate species identification. To our knowledge, proliferative sparganosis attributable to Spirometra sp. 3 has not been reported previously in domestic cats. Given the zoonotic potential of sparganosis, our findings have important implications for both veterinary care and public health surveillance.
20 May 2026 in Journal of the American Veterinary Medical Association
From August to November 2023, a disease outbreak occurred in a research colony of 33 mixed-sex, five-month-old central bearded dragons obtained from a private breeder in the USA. Clinical presentation consisted primarily of dehydration, lethargy, inappetence, weight loss, neck extension, sporadic open mouth breathing indicating dyspnea, and sudden death. A total of six deaths occurred during this period. Pathological investigation followed by molecular diagnostics and whole-genome sequencing revealed Mycoplasma pogonae as the cause of disease. Pneumonia (5/6) was diagnosed from necropsy. Types of pneumonia included histiocytic (1/5), combined histiocytic and lymphocytic (2/5), histiocytic and granulocytic (1/5), and heterophilic pneumonia (1/5). Our results confirmed that M. pogonae infection is associated with sudden mortality in a colony of captive central bearded dragons in the USA and that M. pogonae has a potential pathogenic role as a primary infectious agent.
Schistosomatidae is a family of trematodes that generally have an indirect life cycle, with snails as intermediate hosts in avian schistosomiasis and aquatic birds as definitive hosts. Although multiple studies report avian schistosomes, there are only a few reports describing gross and histological lesions of neuroschistosomiasis in aquatic birds. Herein, a retrospective study including 12 aquatic birds with neuroschistosomiasis was conducted to further characterize the clinical, gross, and histologic findings and to identify the trematodes. The median age of birds was 12 years, and schistosomes were observed in the brain, with or without granulomatous inflammation. Neuroschistosomiasis was likely related to death in 5 out of 12 birds. Twelve formalin-fixed paraffin-embedded (FFPE) samples containing brain, 1 FFPE sample containing intestine, and 1 fresh brain sample were used for polymerase chain reaction (PCR) and sequencing to identify the schistosomes. Dendritobilharzia pulverulenta was identified from 3 out of 13 FFPE samples and 1 fresh brain sample. Neuroschistosomiasis presumptively associated with Dendritobilharzia sp. infection has been reported in swans and geese; however, the identification was based on the clinical signs, lesions, location within the hosts, and the morphology of adult worms without molecular analysis. To the authors’ knowledge, the histologic description and molecular identification of schistosomes that cause neuroschistosomiasis in multiple aquatic bird species other than swans and geese have not been reported.
25 March 2026 in Journal of Veterinary Diagnostic Investigation
A multi-state outbreak of equine botulism occurred between December 2022 and March 2023 in the United States. Follow-up and testing were performed on 42 horses, including 24 that died or were euthanized in the outbreak that affected ~98 horses. Affected horses had all been exposed to the same commercial feed. Clinical signs included progressive muscle weakness and tremors, recumbency, and colic. No significant gross or microscopic abnormalities were observed on autopsy. Feces and gastrointestinal content were tested for various infectious agents, including botulinum toxin; fecal samples from 2 horses tested positive for botulinum neurotoxin (BoNT) type C using the mouse bioassay (MBA). Feed samples, as well as mammalian tissue found within the feed, were collected and tested; 2 samples were positive for BoNT type C by MBA. Based on these results, a diagnosis of botulism was established, and the contaminated feed was identified as the source of exposure. We highlight the diagnostic challenges associated with equine botulism and the importance of regulatory agencies and interagency collaboration during outbreaks.
The mitochondrial membrane protein phosphoglycerate mutase 5 (PGAM5) is a protein of interest in the complex transition from hepatic steatosis to hepatocellular carcinoma. PGAM5 is a serine/threonine/histidine phosphatase that plays a role in mitochondrial biogenesis, mitophagy, and multiple cell death pathways. Increased expression of PGAM5 in hepatocellular carcinoma is correlated with reduced patient survival. In this study, we demonstrate that loss of PGAM5 alters the bioenergetic landscape of liver cancer by promoting mitochondrial oxidant injury and suppressing the glycerophospholipid and lysophospholipid pathways, leading to accumulation of the bioactive phospholipid lysophosphatidylcholine. Additionally, PGAM5 deletion downregulates fatty acid biosynthesis, resulting in reduced cellular diacylglycerol concentrations through two probable mechanisms: attenuated long chain fatty acid uptake and suppressed de novo synthesis. These findings underscore the broad impact of a single phosphatase on mitochondrial function and provide a rationale for therapeutically targeting PGAM5 to disrupt lipid metabolism in hepatocellular carcinoma.